Heritage Pharmaceuticals Inc Clindamycin Palmitate Oral Solution Recall (November 2026)
Announced 2026-08-19 · FDA
Heritage Pharmaceuticals Inc is recalling CLINDAMYCIN PALMITATE HYDROCHLORIDE FOR ORAL SOLUTION, USP, 75 mg/5 mL, 100 mL, Rx Only, distributed nationwide in the United States. The recall is due to the presence of foreign substance—particles and white flakes—in the reconstituted bottles. Recall lot number 2411550; expiration date 2026/NOV.
| Brand | Heritage Pharmaceuticals Inc |
|---|---|
| Product | CLINDAMYCIN PALMITATE HYDROCHLORIDE FOR ORAL SOLUTION, USP, 75 mg/5 mL, Rx Only, 100 mL, Distributed by: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816, NDC 23155-603-51 |
| Reason | Presence of Foreign Substance: presence of particles and white flakes in the reconstituted bottles. |
| Severity | moderate |
| Distribution | Nationwide within the U.S |
| Agency | FDA |
| Recall / campaign no. | Lot #: 2411550, Exp. 2026/NOV. |
WHAT YOU SHOULD DO
- Do not use any bottles from Lot 2411550 (Exp. 2026/NOV).
- Contact your pharmacist or healthcare provider for a replacement, refund, or disposal guidance.
- If you have already used this product, monitor for adverse reactions and contact a clinician if any occur.
- Report adverse events to FDA MedWatch.
This is an automatically maintained record of an official recall notice. Details can change; always follow the official notice linked above. See all records in the Recall Database.